KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Short-term Investments: 2019-2025

Historic Short-term Investments for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $49.4 million.

  • Twist Bioscience's Short-term Investments fell 1.36% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year decrease of 1.36%. This contributed to the annual value of $49.4 million for FY2025, which is 1.36% down from last year.
  • Twist Bioscience's Short-term Investments amounted to $49.4 million in FY2025, which was down 1.36% from $50.1 million recorded in FY2024.
  • Twist Bioscience's Short-term Investments' 5-year high stood at $126.3 million during FY2022, with a 5-year trough of $12.0 million in FY2021.
  • Moreover, its 3-year median value for Short-term Investments was $49.9 million (2023), whereas its average is $49.8 million.
  • Per our database at Business Quant, Twist Bioscience's Short-term Investments crashed by 93.87% in 2021 and then skyrocketed by 949.37% in 2022.
  • Yearly analysis of 5 years shows Twist Bioscience's Short-term Investments stood at $12.0 million in 2021, then skyrocketed by 949.37% to $126.3 million in 2022, then plummeted by 60.45% to $49.9 million in 2023, then climbed by 0.28% to $50.1 million in 2024, then fell by 1.36% to $49.4 million in 2025.